Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of Varicella Immunity in Hospital Employees
NCT02026089Phase 4Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of varicella virus vaccine live in chickenpox, sponsored by University of Colorado Denver. Planned start Dec 2021; status: withdrawn.
02
Drugs
varicella virus vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on NCT02026089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02026089.